Clinical Trials · NCT00026377
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- University of Chicago
- Enrollment
- 3
- Start date
- Nov 2001
- Locations
- 3 sites, United States
- Primary endpoint
- Side effects of SU5416 in combination with standard hormone treatment and radiation in men with prostate cancer